CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
They also released the Operational Guidelines for Wellness activities at AB-HWCs
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
Subscribe To Our Newsletter & Stay Updated
